rss
BMJ Case Reports 2009; doi:10.1136/bcr.06.2009.1931
  • Unexpected outcome (positive or negative) including adverse drug reactions

Rhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate

  1. Premnath Reddy Karre1,
  2. Jeetinder Gujral2,
  3. Ernesto Rodriguez1
  1. 1
    North Shore/LIJ-Southside Hospital, Family Medicine Residency Program, Bay Shore, New York, 11706, USA
  2. 2
    North Shore/LIJ-Southside Hospital, Hospitalist, Bay Shore, New York, 11706, USA
  1. Premnath Reddy Karre, karreprn{at}gmail.com
  • Published 17 August 2009

Summary

A 56-year-old African American female with a history of schizophrenia developed rhabdomyolysis with creatine phosphokinase (CPK) levels of 5172 U/L after intramuscular injection of haloperidol decanoate. The patient was admitted to the hospital and treated with saline infusion alone. Serum CPK levels were decreased but not significantly so even after 4 days. Renal function tests and vital signs remained normal throughout her stay in the hospital. Urinary alkalinisation was done with sodium bicarbonate to maintain urine pH higher than 6.5 and the CPK levels declined gradually over the next 3 days. The patient was observed for 24 hours without saline infusion and urine alkalinisation but the serum CPK levels continued to increase and this regimen was restarted. The patient stayed in the hospital for 4 weeks on this regimen until the CPK levels decreased and remained normal. Our patient developed rhabdomyolysis without neuroleptic malignant syndrome.

Footnotes

  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog